Arizona’s attorney general has asked the U.S. Department of Health and Human Services (HHS) to make clear that health care providers cannot use race as a factor in determining who can receive COVID-19 treatments.
The Food and Drug Administration, an agency inside HHS, recently issued guidance advising health care providers to take race into account when allocating doses of Sotrovimab, a monoclonal antibody treatment.
